PE anti-mouse/rat CD29 Antibody

Pricing & Availability
HMβ1-1 (See other available formats)
Regulatory Status
Other Names
integrin β1, VLA-β chain, β1 integrin, GPIIa, ITGB1
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
Lou rat bone marrow cells stained with HMβ1-1 biotin, then detected with Sav-PE
  • Hmβ1-1
    Lou rat bone marrow cells stained with HMβ1-1 biotin, then detected with Sav-PE
  • HMβ1-1_mouse
    Lou rat bone marrow cells stained with HMβ1-1 biotin, then detected with Sav-PE
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
102207 50 µg 104€
Check Availability

Need larger quantities of this item?
Request Bulk Quote
102208 200 µg 283€
Check Availability

Need larger quantities of this item?
Request Bulk Quote

CD29 is a 130 kD protein, also known as integrin β1, VLA-β chain, or GPIIa. It is a member of the integrin family, expressed broadly on leukocytes, endothelial cells, smooth muscle, and epithelial cells. In association with CD49a-f, CD29 forms the VLA-1 through VLA-6 complexes, respectively. It plays an important role in cell-cell or cell-matrix interaction. The HMß1-1 antibody reacts with both mouse and rat CD29. It is able to block cell adhesion and inhibit T cell proliferation.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Rat
Antibody Type
Host Species
Armenian Hamster
Purified mouse VLA-4 (α4β1, CD49d/CD29)
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1, immunohistochemistry4 of acetone-fixed frozen sections, in vitro blocking of the adhesion of mouse tumor cell lines to extracellular matrix proteins and in vitro inhibition of T cell proliferative responses1, and in vivo inhibition of neutrophil migration2. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 102235 and 102236).

Application References

(PubMed link indicates BioLegend citation)
  1. Noto K, et al. 1995. Int. Immunol. 7:835.
  2. Ridger VC, et al. 2001. J. Immunol. 166:3484.
  3. Jia W, et al. 2005. Blood 106:3854.PubMed
  4. Economopoulou M, et al. 2005. Blood 106:3831.
  5. Lawson BR, et al. 2007. J. Immunol. 178:5366.
  6. Eisenmann KM, et al. 2007. J. Biol. Chem. doi:10.1074/jbc.M703243200.PubMed
  7. Hayashi Y, et al. 2008. Am J Physiol Gastrointest Liver Physiol. 294:G778. PubMed
  8. Kim DT, et al. 2008. Blood 111:2929.PubMed
  9. Hayashi Y, et al. 2008. J Pharmacol Exp Ther. 326:523. PubMed
  10. Carlson TR, et al. 2008. Development. 135:2193. PubMed
  11. Sangaletti S, et al. 2008. Cancer Res. 68:9050. (Block) PubMed
  12. Baker CM, et al. 2012. PNAS. PubMed.
  13. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
Product Citations
  1. Wang X, et al. 2022. Genes (Basel). 13:. PubMed
  2. Lu JH, et al. 2023. J Funct Biomater. 14:. PubMed
  3. Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed
  4. Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed
  5. Guo SS, et al. 2020. Development. . PubMed
  6. Huang N, et al. 2022. Stem Cells Int. 2022:9977610. PubMed
  7. Yang J, et al. 2022. Dis Markers. 2022:7071877. PubMed
  8. Wei H, et al. 2021. Mol Med Rep. 23:00. PubMed
  9. Vallant N, et al. 2021. Int J Mol Sci. 22:00. PubMed
  10. Bo Yu et al. 2018. Cell stem cell. 23(2):193-209 . PubMed
  11. Benito-Jardón M, et al. 2020. J Cell Biol. 219: . PubMed
  12. Li C, et al. 2022. Neural Regen Res. 17:2050. PubMed
  13. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  14. Larouche JA, et al. 2021. eLife. 0.416666666666667. PubMed
  15. Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed
  16. Yin M, et al. 2019. Int J Mol Med. 43:2086. PubMed
  17. Lan WR, et al. 2019. Stem Cells Int. 2019:8404168. PubMed
  18. Lai G, et al. 2022. PeerJ. 10:e13744. PubMed
  19. Weckbach L, et al. 2014. Blood. 123:1887. PubMed
  20. Nishina T, et al. 2021. Nat Commun. 12:2281. PubMed
  21. Tang S, et al. 2021. Front Cell Dev Biol. 9:670913. PubMed
  22. Mittal S, et al. 2016. Stem Cell Reports. 7:583-590. PubMed
  23. Huang L, et al. 2016. J Biol Chem. 291: 6232 - 6244. PubMed
  24. Toda S, et al. 2014. Blood. 123:3963. PubMed
  25. Zuba-Surma E, et al. 2008. J Mol Cell Cardiol. 44:865. PubMed
  26. Gross ETE, et al. 2018. Oncoimmunology. 8:e1404212. PubMed
  27. Jiang M, et al. 2020. Exp Ther Med. 1.989583333. PubMed
  28. Chen NP, et al. 2022. Nat Cell Biol. 24:723. PubMed
  29. Paterson N, et al. 2022. Elife. 11:. PubMed
  30. Diaferia G, et al. 2013. Development. 140:3360. PubMed
  31. Moretti FA, et al. 2018. Elife. 7:e35816. PubMed
  32. Shcherbina A, et al. 2020. Cell Rep. 32:107964. PubMed
  33. Yamamoto M, et al. 2019. Commun Biol. 2:292. PubMed
  34. Zaghdoudi S, et al. 2020. EMBO Mol Med. 12:e12010. PubMed
  35. Gomzikova MO, et al. 2020. Sci Rep. 10:10740. PubMed
  36. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  37. Simonetti G, et al. 2013. J Exp Med. 210:2887. PubMed
  38. Zografou A, et al. 2011. J Plast Reconstr Aesthet Surg. 64:1647. PubMed
  39. Zheng Z, et al. 2012. Biochem Biophys Res Commun. 428:309. PubMed
  40. Kurzrock E, et al. 2008. Am J Physiol Renal Physiol. 294:F1415. PubMed
  41. Masgutov R, et al. 2018. Front Pharmacol. 9:86. PubMed
  42. Stepp M, et al. 2007. J Cell Sci. 120:2851. PubMed
  43. Izawa Y, et al. 2018. J Cereb Blood Flow Metab. 38:641. PubMed
  44. Shi C, et al. 2015. Biomaterials. 58: 10-25. PubMed
  45. Deng P, et al. 2021. Cell Stem Cell. 28(6):1057-1073.e7. PubMed
  46. Santini MP, et al. 2020. Cell Rep. 30:555. PubMed
  47. Si H, et al. 2018. Int J Mol Med. 41:3342. PubMed
  48. Markworth JF, et al. 2020. JCI Insight. 5:00. PubMed
  49. Bauer M, et al. 2009. Proc Natl Acad Sci U S A. 106:1920. PubMed
  50. Liang C, et al. 2013. Acta Biomater. 9:9423. PubMed
  51. Cizkova D, et al. 2014. Sci Rep. 4:7514. PubMed
  52. Cobbold SP, et al. 2018. Front Immunol. 9:1381. PubMed
  53. Wang T, et al. 2022. Nat Commun. 13:160. PubMed
AB_312884 (BioLegend Cat. No. 102207)
AB_312885 (BioLegend Cat. No. 102208)

Antigen Details

Integrin family, 130 kD

Leukocytes, endothelial cells, smooth muscle, epithelial cells

Extracellular matrix
Cell Type
Embryonic Stem Cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Innate Immunity, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Noto K, et al. 1995. Int. Immunol. 7:835.
2. Springer TA. 1990. Nature 346:425.

Gene ID
16412 View all products for this Gene ID 24511 View all products for this Gene ID
View information about CD29 on

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.


This product is supplied subject to the terms and conditions, including the limited license, located at ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.


BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.


8999 BioLegend Way, San Diego, CA 92121
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.


Login / Register
Remember me
Forgot your password? Reset password?
Create an Account